Fractals: Life Science Conversations

From Big Pharma to Biotech: Lessons in Patient-Centered Drug Development with Dr. David Krause

Episode Notes

What does it take to lead successful drug development—whether at a global pharma giant or a small biotech start-up?

In this episode of SNiPs, Dr. David Krause joins Bracken CEO Dr. Colin Miller to reflect on three decades of experience spanning large organizations like GSK to fast-moving start-ups. From aligning clinical development with medical affairs to serving “many masters” in drug development, patients, regulators, providers, and marketers, Dr. Krause shares insights on how to keep the patient at the center while driving innovation forward.

Topics include:

• Lessons learned moving from big pharma to start-ups
• The evolving relationship between medical affairs and clinical development
• Balancing regulatory, commercial, and patient priorities
• Why knowing what you don’t know is key to success in smaller companies

Listen to this episode of Fractals: Life Science Conversations wherever you get your podcasts—and connect with Bracken to learn how we support drug development from concept to approval.